Cenexi | Cenexi Laboratoires Thissen

Cenexi acquired this site (Formerly laboratoires Thissen) in 2012. The plant is a major manufacturer of sterile highly potent compounds and offers various sterile dosage forms for oncological purposes. The site thus manufactures sterile, liquid, and freeze-dried vials as well as pre-filled syringes for customers with varied profiles: Big Pharmas, startups, young innovative biotechs or generics, from all over the world. The site is also home to 40 of the 110 Cenexi Services experts*, the entity supporting formulation activities, analytical and pharmaceutical form developments, industrial transfer, and regulatory support for experimental products or products already on the market to be manufactured on Cenexi sites. As such, Cenexi Braine-l Alleud has a sterile products development unit with three components: analytical development, pharmaceutical development, and two pilot production units (Clean rooms GMP accredited by the authorities), for the manufacture of early development phase batches and clinical batches. This unit specializes in high potent products (cytotoxics), biological products (monoclonal antibodies, proteins, antibody-drug conjugation, viruses), and narcotic substances. The site accommodates the entire drug manufacturing process, from formulation to pilot-scale production and transfer to production units.